BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Hepatol. Apr 27, 2026; 18(4): 116176
Published online Apr 27, 2026. doi: 10.4254/wjh.v18.i4.116176
In-hospital mortality and dynamic modified end-stage liver disease score after emergency general surgery in patients with cirrhosis
Ashling L Zhang, Nathnael Tessema, Jaclyn Clark, Roumen Vesselinov, Lindsay O’Meara, David T Efron, Mira H Ghneim
Ashling L Zhang, Nathnael Tessema, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, United States
Jaclyn Clark, David T Efron, Mira H Ghneim, Program in Trauma, University of Maryland School of Medicine, R. Adams Cowley Shock Trauma Center, Baltimore, MD 21201, United States
Roumen Vesselinov, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD 21201, United States
Lindsay O’Meara, Department of Surgery, University of Maryland Medical Center, Baltimore, MD 21201, United States
Author contributions: Zhang AL and Tessema N extracted data from medical records; Zhang AL and Ghneim MH designed the study and were major contributors to the writing of the manuscript; Zhang AL, Vesselinov R, and Ghneim MH performed the statistical analyses; Clark J, O’Meara L, and Efron DT contributed to critical revision of the manuscript; All authors read, revised, and approved the final manuscript.
Institutional review board statement: The study protocol was reviewed and approved by the University of Maryland, Baltimore Institutional Review Board (Approval No. HP-00112669).
Informed consent statement: Patients were not required to give informed consent to the study, because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
Data sharing statement: The datasets generated during the current study are not publicly available due to sensitivity and are available from the corresponding author on reasonable request.
Corresponding author: Mira H Ghneim, MD, Associate Professor, FACS, Program in Trauma, University of Maryland School of Medicine, R. Adams Cowley Shock Trauma Center, 22 S. Greene Street, Baltimore, MD 21201, United States. mira.ghneim@som.umaryland.edu
Received: November 5, 2025
Revised: December 9, 2025
Accepted: January 20, 2026
Published online: April 27, 2026
Processing time: 168 Days and 6.5 Hours
Abstract
BACKGROUND

Improvement in care has resulted in a greater incidence of patients with cirrhosis requiring emergency general surgery procedures (EGSPs). Understanding perioperative risk factors is essential to guide surgical decision-making and optimize outcomes in this high-risk population.

AIM

To describe perioperative characteristics and outcomes of and identify risk factors for in-hospital mortality among patients with cirrhosis requiring EGSP.

METHODS

This was a retrospective study of patients with cirrhosis who underwent EGSP at a single quaternary care center from 2016 to 2023. Data collected included demographics, disease characteristics, perioperative management, and outcomes. The primary outcome was in-hospital mortality. Multivariable logistic regression models were employed to identify factors independently associated with in-hospital mortality. P < 0.05 was considered statistically significant.

RESULTS

Of the 94 patients included, 69% survived. In-hospital mortality was 31%. Non-survivors presented with higher model for end-stage liver disease (MELD) scores (26 vs 13; P < 0.001), had more complex surgical pathology, and suffered more non-surgical complications (97% vs 57%; P < 0.001). Of the 24 patients with improved MELD scores, 92% survived; conversely, of the 14 patients whose MELD scores worsened, 93% died. All patients with a final MELD ≥ 30 died. Worsening MELD was primarily driven by bilirubin and creatinine rather than international normalized ratio. In the adjusted model, preoperative vasopressors (odds ratio [OR]: 18, 95% confidence interval [CI]: 2.9-116) and MELD score at discharge/death (OR: 1.3, 95%CI: 1.1-1.4) were independently associated with in-hospital mortality.

CONCLUSION

In patients with cirrhosis requiring EGSP, initial MELD alone may be insufficient for assessing risk of in-hospital mortality, as it can change postoperatively and may improve after indicated intervention. Postoperative MELD trajectory aligned with prognosis, and increasing MELD – primarily driven by bilirubin and creatinine – was associated with higher in-hospital mortality, highlighting potential targets for postoperative risk mitigation.

Keywords: Emergency general surgery; Cirrhosis; Outcomes; Mortality; Model for end-stage liver disease

Core Tip: For patients with cirrhosis requiring emergency general surgery, initial model for end-stage liver disease (MELD) score alone may be insufficient for perioperative risk assessment, as MELD can change postoperatively. In this single-center retrospective study of 94 patients, MELD at discharge/death was independently associated with in-hospital mortality, whereas admission and day-of-surgery MELD were not. Among 24 patients whose MELD improved after surgery, 92% survived; among 14 whose MELD worsened, 93% died. All patients with final MELD ≥ 30 died. Increases in MELD were driven by bilirubin and creatinine, highlighting the need for targeted postoperative strategies to limit renal and hepatic dysfunction.